| Primary |
| Major Depression |
21.4% |
| Depression |
17.9% |
| Product Used For Unknown Indication |
17.9% |
| Cataplexy |
7.1% |
| Antidepressant Therapy |
3.6% |
| Attention Deficit/hyperactivity Disorder |
3.6% |
| Bladder Disorder |
3.6% |
| Divorced |
3.6% |
| Drug Abuser |
3.6% |
| Hypertension |
3.6% |
| Incontinence |
3.6% |
| Migraine |
3.6% |
| Narcolepsy |
3.6% |
| Urinary Incontinence |
3.6% |
|
| Cataract |
5.3% |
| Diabetic Retinopathy |
5.3% |
| Fatigue |
5.3% |
| Floppy Iris Syndrome |
5.3% |
| Gun Shot Wound |
5.3% |
| Hepatic Steatosis |
5.3% |
| Hyperhidrosis |
5.3% |
| Intracranial Aneurysm |
5.3% |
| Medication Error |
5.3% |
| Multiple Drug Overdose |
5.3% |
| Neurotoxicity |
5.3% |
| Psychotic Disorder |
5.3% |
| Rib Fracture |
5.3% |
| Self Injurious Behaviour |
5.3% |
| Somnambulism |
5.3% |
| Somnolence |
5.3% |
| Therapeutic Response Unexpected With Drug Substitution |
5.3% |
| Thinking Abnormal |
5.3% |
| White Blood Cell Count Increased |
5.3% |
|
| Secondary |
| Product Used For Unknown Indication |
40.7% |
| Major Depression |
22.2% |
| Paranoia |
7.4% |
| Anxiety |
3.7% |
| Depression |
3.7% |
| Enuresis |
3.7% |
| Hypertension |
3.7% |
| Hypertonic Bladder |
3.7% |
| Nausea |
3.7% |
| Pneumonia |
3.7% |
| Sleep Disorder |
3.7% |
|
| Completed Suicide |
20.0% |
| Serotonin Syndrome |
20.0% |
| Agitation |
10.0% |
| Drug Ineffective |
10.0% |
| Ileus Paralytic |
10.0% |
| Neurotoxicity |
10.0% |
| No Adverse Event |
10.0% |
| Paraesthesia Oral |
10.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.0% |
| Hypertension |
12.1% |
| Depression |
10.1% |
| Pain |
4.0% |
| Anxiety |
3.8% |
| Osteoporosis |
3.8% |
| Premedication |
3.3% |
| Gastric Ulcer |
3.0% |
| Migraine |
3.0% |
| Multiple Sclerosis |
3.0% |
| Acute Coronary Syndrome |
2.8% |
| Vitamin Supplementation |
2.8% |
| Acute Myeloid Leukaemia |
2.5% |
| Medical Diet |
2.5% |
| Bipolar Disorder |
2.0% |
| Insomnia |
2.0% |
| Psoriasis |
2.0% |
| Diabetes Mellitus |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Hiv Infection |
1.8% |
|
| Type 2 Diabetes Mellitus |
16.0% |
| Fall |
6.0% |
| Pain |
6.0% |
| Pulmonary Embolism |
6.0% |
| Seborrhoeic Dermatitis |
6.0% |
| Chest Pain |
4.0% |
| Cleft Palate |
4.0% |
| Constipation |
4.0% |
| Diabetes Mellitus |
4.0% |
| Fatigue |
4.0% |
| Flushing |
4.0% |
| Granulocytopenia |
4.0% |
| Injection Site Pain |
4.0% |
| Lung Neoplasm Malignant |
4.0% |
| Malignant Melanoma In Situ |
4.0% |
| Melanocytic Naevus |
4.0% |
| No Adverse Event |
4.0% |
| Off Label Use |
4.0% |
| Organ Failure |
4.0% |
| Pyrexia |
4.0% |
|
